Bellevue Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.1M | Sell |
|
|||||
|
2025
Q1 | $72.7M | Buy |
|
|||||
|
2024
Q4 | $81.3M | Buy |
|
|||||
|
2024
Q3 | $68.2M | Sell |
|
|||||
|
2024
Q2 | $144M | Buy |
|
|||||
|
2024
Q1 | $169M | Buy |
|
|||||
|
2023
Q4 | $113M | Buy |
|
|||||
|
2023
Q3 | $64M | Sell |
|
|||||
|
2023
Q2 | $97.9M | Buy |
|
|||||
|
2023
Q1 | $87.7M | Sell |
|
|||||
|
2022
Q4 | $112M | Buy |
|
|||||
|
2022
Q3 | $69.3M | Sell |
|
|||||
|
2022
Q2 | $69.2M | Sell |
|
|||||
|
2022
Q1 | $120M | Sell |
|
|||||
|
2021
Q4 | $126M | Sell |
|
|||||
|
2021
Q3 | $144M | Buy |
|
|||||
|
2021
Q2 | $105M | Buy |
|
|||||
|
2021
Q1 | $77.7M | Buy |
|
|||||
|
2020
Q4 | $78.9M | Buy |
|
|||||
|
2020
Q3 | $50.2M | Buy |
|
|||||
|
2020
Q2 | $41.6M | Buy |
|
|||||
|
2020
Q1 | $27.3M | Buy |
|
|||||
|
2019
Q4 | $17.2M | Sell |
|
|||||
|
2019
Q3 | $25.2M | Buy |
|
|||||
|
2019
Q2 | $24.7M | Buy |
|
|||||
|
2019
Q1 | $15.6M | Buy |
|
|||||
|
2018
Q4 | $9.32M | Buy |
|
|||||
|
2018
Q3 | $10.2M | Sell |
|
|||||
|
2018
Q2 | $25.7M | Sell |
|
|||||
|
2018
Q1 | $26.4M | Buy |
|
|||||
|
2017
Q4 | $15.3M | Buy |
|
|||||
|
2017
Q3 | $2.2M | Buy |
|
|||||
|
2017
Q2 | $2.74M | Buy |
|
|||||
|
2017
Q1 | $3.06M | Sell |
|
|||||
|
2016
Q4 | $2.45M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.36M | Buy |
|